Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
(Sharecast News) - The US Food and Drug Administration has approved ViiV Healthcare's Cabenuva (cabotegravir, rilpivirine) for the treatment of HIV-1 in virologically-suppressed adults.
Read more
GSK's Viiv Healthcare gets FDA approval for new dose of HIV treatment
Read more
By Deena BeasleyJan 31 (Reuters) - Merck & Co's new antiviral pill, once touted as a potential game changer for treating COVID-19, is the last choice among four available options for at-risk patients given its relatively low efficacy and potential...
Read moreBy Deena BeasleyJan 31 (Reuters) - Rival antiviral pills from Pfizer Inc and Merck & Co that demonstrated efficacy in trials of adults with COVID-19 who are at high risk of serious illness are now both in use. The drugs are being studied to see ...
Read morePRESS: Activist investor Cevian builds stake in Vodafone - Bloomberg
Read moreLONDON BROKER RATINGS: Barclays lifts ITV and S4 Capital to Overweight
Read moreLONDON BROKER RATINGS: Fresnillo and Polymetal hit by downgrades
Read moreUnilever undergoes "spring clean" amid investor pressure
Read moreBy Svea Herbst-BaylissBOSTON, Jan 25 (Reuters) - Two and a half years ago Nelson Peltz, the billionaire activist investor who often presents himself as a partner with constructive advice for companies, told an audience of pension and hedge funds t...
Read moreJan 25 (Reuters) - Unilever unveiled plans on Tuesday to cut about 1,500 management jobs in an overhaul aimed at easing shareholders' concerns after a failed acquisition and news an activist investor had built a stake in the consumer goods giant....
Read moreTOP NEWS: Under pressure Unilever to cut 1,500 jobs amid restructure
Read more* To create five product-focused divisions* Long-planned revamp comes after failed bid for GSK unit* Comes amid news of stakebuilding by activist investor (Adds detail, link to FOCUS)By Richa Naidu and Pushkala AripakaLONDON, Jan 25 (Reuters) - Unil...
Read more* To create five product-focused divisions* Long-planned revamp comes after failed bid for GSK unit* Comes amid news of stakebuilding by activist investor (Adds investor comment)By Richa Naidu and Pushkala AripakaLONDON, Jan 25 (Reuters) - Unilever ...
Read more* To create five product-focused divisions* Long-planned revamp comes after failed bid for GSK unit* Comes amid news of stakebuilding by activist investor (Adds graphic, comments from analyst and restructuring expert)By Richa Naidu and Pushkala Arip...
Read more* To create five product-focused divisions* Long-planned revamp comes after failed bid for GSK unit* Comes amid news of stakebuilding by activist investor (Adds background, details, analyst comment)By Richa Naidu and Pushkala AripakaLONDON, Jan 25 (...
Read more
Last checked at